PSR is the leading expert in orphan drug development. We assist our clients to design and execute successful clinical development strategies for orphan indications. We are specialized in complex clinical development programs requiring innovative regulatory and clinical approaches.
Biocortech is focusing on developing diagnostic application of receptor editing, an emerging field of rapidly growing interest that the company pioneered for the last years. Biocortech is now addressing the emerging market of biological testing of neuropsychiatric diseases and aiming at being an early entrant in the market of biological testing of depression, with a proprietary blood test.
Bezwada Biomedical LLC is an innovation based and technology driven start up company focused on developing a range of novel, biocompatible and absorbable materials for use in next generation medical devices and therapeutic applications. Since our inception in 2003, our mission is to use the transforming power of chemistry to innovate and develop a range of biodegradable polymers that represent platform technologies capable of generating products that can improve the health and quality of patients’ lives.
Baxano Surgical is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region. We are committed to delivering minimally invasive surgical technologies that enhance patient clinical care while providing sustained value for our customers.
At Avanti Polar Lipids, Inc., our mission is to provide research and pharmaceutical scientists with the highest quality phospholipids, sphingolipids and sterols. To accomplish our mission, Avanti uses only the finest precursors and reagents and our highly trained staff utilize proven methods and procedures to ensure the quality of the final product. Each product is certified by our analytical specialists according to a rigorous set of specifications.
Asiatic Clinical Research is a full service clinical research organization (CRO) headquartered in Bangalore, India. We focus on Phase II - IV clinical trial support to pharmaceutical, biotechnology and medical device companies. Our strength is in strategizing what is exactly needed for your clinical trial by conducting a good literature search, providing world class facilities, KOL in specific indications treatment naïve patient pools. Asiatic has access to ICH-GCP trained sites in metros and tier II cities.
apceth is one of the leading European pioneers in the development, manufacturing and clinical implementation of innovative cell therapeutics. apceth’s unique platform technology employs human adult stem cells in order to produce cell products of the highest quality according to the EU regulations for Advanced Therapy Medicinal Products (ATMPs). The growing portfolio of apceth’s cell therapeutics aims for the treatment of advanced cancer and various nonmalignant diseases where standard medicine fails to achieve satisfactory results.
Amunix was founded in 2006 by Willem 'Pim' Stemmer and Volker Schellenberger. It has now grown to encompass 30 employees, a dedicated in-house patent attorney, and over 12,000 square feet of research labs. Our primary focus continues to be the design and preclinical development of protein pharmaceuticals with extended serum half-lives through the application of our XTEN technology platform. Central to our platform, XTEN is a hydrophilic, unstructured polypeptide which imparts a number of favorable properties to the molecules to which it has been fused.
Around the world there are still many diseases for which no effective treatments exist and many patients who do not have adequate access to the medicines they need. As a global pharmaceutical company addressing these unmet medical needs, Eisai is committed to making contributions to better healthcare for patients and their families around the world through its business activities.